P140 Reduction in serum ferritin (SF) is associated with improvement in liver transaminase levels during treatment with deferasirox (Exjade®) in ironoverloaded patients with myelodysplastic syndromes (MDS)

N. Gattermann; M. Schmid; A. Guerci-Bresler; M. Della Porta; K. Taylor; D. Habr; G. Domokos; B. Roubert; P. Fenaux

doi:10.1016/S0145-2126(09)70221-8

P140 Reduction in serum ferritin (SF) is associated with improvement in liver transaminase levels during treatment with deferasirox (Exjade®) in ironoverloaded patients with myelodysplastic syndromes (MDS)

N. Gattermann, M. Schmid, A. Guerci-Bresler, M. Della Porta, K. Taylor, D. Habr, G. Domokos, B. Roubert, P. Fenaux

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Leukemia Research
Volume	33
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1016/S0145-2126(09)70221-8
Publication status	Published - May 2009

ASJC Scopus subject areas

Cancer Research
Hematology
Oncology

Access to Document

10.1016/S0145-2126(09)70221-8

Cite this

Gattermann, N., Schmid, M., Guerci-Bresler, A., Della Porta, M., Taylor, K., Habr, D., Domokos, G., Roubert, B., & Fenaux, P. (2009). P140 Reduction in serum ferritin (SF) is associated with improvement in liver transaminase levels during treatment with deferasirox (Exjade®) in ironoverloaded patients with myelodysplastic syndromes (MDS). Leukemia Research, 33(SUPPL. 1). https://doi.org/10.1016/S0145-2126(09)70221-8

P140 Reduction in serum ferritin (SF) is associated with improvement in liver transaminase levels during treatment with deferasirox (Exjade®) in ironoverloaded patients with myelodysplastic syndromes (MDS). / Gattermann, N.; Schmid, M.; Guerci-Bresler, A. et al.

In: Leukemia Research, Vol. 33, No. SUPPL. 1, 05.2009.

Research output: Contribution to journal › Article › peer-review

Gattermann, N, Schmid, M, Guerci-Bresler, A, Della Porta, M, Taylor, K, Habr, D, Domokos, G, Roubert, B & Fenaux, P 2009, 'P140 Reduction in serum ferritin (SF) is associated with improvement in liver transaminase levels during treatment with deferasirox (Exjade®) in ironoverloaded patients with myelodysplastic syndromes (MDS)', Leukemia Research, vol. 33, no. SUPPL. 1. https://doi.org/10.1016/S0145-2126(09)70221-8

Gattermann N, Schmid M, Guerci-Bresler A, Della Porta M, Taylor K, Habr D et al. P140 Reduction in serum ferritin (SF) is associated with improvement in liver transaminase levels during treatment with deferasirox (Exjade®) in ironoverloaded patients with myelodysplastic syndromes (MDS). Leukemia Research. 2009 May;33(SUPPL. 1). https://doi.org/10.1016/S0145-2126(09)70221-8

@article{5b266673ef604a268d0be7c374bdb552,

title = "P140 Reduction in serum ferritin (SF) is associated with improvement in liver transaminase levels during treatment with deferasirox (Exjade{\textregistered}) in ironoverloaded patients with myelodysplastic syndromes (MDS)",

author = "N. Gattermann and M. Schmid and A. Guerci-Bresler and {Della Porta}, M. and K. Taylor and D. Habr and G. Domokos and B. Roubert and P. Fenaux",

year = "2009",

month = may,

doi = "10.1016/S0145-2126(09)70221-8",

language = "English",

volume = "33",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Ltd",

number = "SUPPL. 1",

}

TY - JOUR

T1 - P140 Reduction in serum ferritin (SF) is associated with improvement in liver transaminase levels during treatment with deferasirox (Exjade®) in ironoverloaded patients with myelodysplastic syndromes (MDS)

AU - Gattermann, N.

AU - Schmid, M.

AU - Guerci-Bresler, A.

AU - Della Porta, M.

AU - Taylor, K.

AU - Habr, D.

AU - Domokos, G.

AU - Roubert, B.

AU - Fenaux, P.

PY - 2009/5

Y1 - 2009/5

UR - http://www.scopus.com/inward/record.url?scp=65349118807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65349118807&partnerID=8YFLogxK

U2 - 10.1016/S0145-2126(09)70221-8

DO - 10.1016/S0145-2126(09)70221-8

M3 - Article

AN - SCOPUS:65349118807

VL - 33

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - SUPPL. 1

ER -

P140 Reduction in serum ferritin (SF) is associated with improvement in liver transaminase levels during treatment with deferasirox (Exjade®) in ironoverloaded patients with myelodysplastic syndromes (MDS)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this